References
- Wozney J. M., Rosen V., Celeste A. J., Mitsock L. M., Whitters M. J., Kriz R. W., Hewick R. M., Wang E. A. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528–1534
- Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs and Cbfa1. Endocr. Rev. 2000; 21: 393–411, [CSA], [CROSSREF]
- Riedel G. E., Valentin‐Opran A. Clinical evaluation of rhBMP‐2/ACS in orthopedic trauma: a progress report. Orthopedics 1999; 22: 663–665, [CSA]
- Boden S. D., Zdeblick T. A., Sandhu H. S., Heim S. E. The use of rhBMP‐2 in interbody fusion cages. Spine 2000; 25: 376–381, [CSA], [CROSSREF]
- Cook S. D. Preclinical and clinical evaluation of osteogenic protein‐1 (BMP‐7) in bony sites. Orthopedics 1999; 22: 669–671, [CSA]
- Boden S. D., Martin G. J., Jr., Morone M. A., Ugbo J. L., Moskovitz P. A. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxapatite‐tricalcium phosphate after laminectomy in the nonhuman primate. Spine 1999; 24: 1179–1185, [CSA], [CROSSREF]
- Saito N., Okada T., Toba S., Miyamoto S., Takaoka K. New synthetic absorbable polymers as BMP carriers: plastic properties of poly‐D,L‐lactic acid‐polyethylene glycol block copolymers. J. Biomed. Mater. Res. 1999; 47: 104–110, [CSA]
- Renier M. L., Kohn D. H. Development and characterization of a biodegradable polyphosphate. J. Biomed. Mater. Res. 1997; 34: 95–104, [CSA]
- Boyne P. J., Marx R. E., Nevins M., Triplett G., Lazaro E., Lilly L. C., Alder M., Nummikoski P. A feasibility study evaluating rhBMP‐2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodontics Restor. Dent. 1997; 17: 11–25, [CSA]
- Uludag H., D'Augusta D., Palmer R., Timony G., Wozney J. Characterization of rhBMP‐2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 1999; 46: 193–202, [CSA], [CROSSREF]
- Whang K., Tsai D. C., Nam E. K., Aitken M., Sprague S. M., Patel P. K., Healy K. E. Ectopic bone formation via rhBMP‐2 delivery from porous bioabsorbable polymer scaffolds. J. Biomed. Mater. Res. 1998; 42: 491–499, [CSA], [CROSSREF]
- Fujioka K., Takada Y., Sato S., Miyata T. Novel delivery system for proteins using collagen as a carrier material: the minipellet. J. Control. Release 1995; 33: 307–315, [CROSSREF]
- Rubin A. L., Miyata T., Stenzel K. H. Collagen: medical and surgical applications. J. Macromol. Sci.–Chem. 1969; A3: 113–118
- Maeda H., Sano A., Fujioka K. Controlled release of rhBMP‐2 from collagen minipellet and the relationship between release profile and ectopic bone formation. Int. J. Pharm. 2004; 275: 109–122, [CROSSREF]
- Fujioka K., Takada Y., Sato S., Miyata T. Long‐acting delivery system of interferon, IFN minipellet. J. Control. Release 1995; 33: 317–323, [CROSSREF]
- Maeda H., Nakagawa T., Adachi N., Sakai Y., Yamamoto T., Matsuoka A., Sano A., Satoh Y., Miyata T., Fujioka K. Design of long‐acting formulation of protein drugs with a double‐layer structure and its application to rhG‐CSF. J. Control. Release 2003; 91: 281–297, [CSA], [CROSSREF]
- Maeda H., Ohtsuka T., Maeda M., Sasaki Y., Sato S., Fujioka K. Novel sustained release formulation using collagen as a carrier material, 1, dosage form design of interferon minipellet. Drug Deliv. Syst. 1996; 11: 175–181
- Maeda M., Tani S., Sano A., Fujioka K. Microstructure and release characteristics of the minipellet, a collagen‐based drug delivery system for controlled release of protein drugs. J. Control. Release 1999; 62: 313–324, [CSA], [CROSSREF]